Alteration of topoisomerase II-alpha gene in human breast cancer: association with responsiveness to anthracycline-based chemotherapy.

MLA

Press, Michael F., et al. “Alteration of Topoisomerase II-Alpha Gene in Human Breast Cancer: Association with Responsiveness to Anthracycline-Based Chemotherapy.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, vol. 29, no. 7, Mar. 2011, pp. 859–67. EBSCOhost, https://doi.org/10.1200/JCO.2009.27.5644.

APA

Press, M. F., Sauter, G., Buyse, M., Bernstein, L., Guzman, R., Santiago, A., Villalobos, I. E., Eiermann, W., Pienkowski, T., Martin, M., Robert, N., Crown, J., Bee, V., Taupin, H., Flom, K. J., Tabah-Fisch, I., Pauletti, G., Lindsay, M.-A., Riva, A., & Slamon, D. J. (2011). Alteration of topoisomerase II-alpha gene in human breast cancer: association with responsiveness to anthracycline-based chemotherapy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 29(7), 859–867. https://doi.org/10.1200/JCO.2009.27.5644

Chicago

Press, Michael F, Guido Sauter, Marc Buyse, Leslie Bernstein, Roberta Guzman, Angela Santiago, Ivonne E Villalobos, et al. 2011. “Alteration of Topoisomerase II-Alpha Gene in Human Breast Cancer: Association with Responsiveness to Anthracycline-Based Chemotherapy.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 29 (7): 859–67. doi:10.1200/JCO.2009.27.5644.